Lepu Medical released its 2026 interim report, with net profit attributable to the parent company of 499 million yuan, a decrease of 27.71% compared with the same period last year. The company's total operating revenue was 3.214 billion yuan, down 4.61% year-on-year; net cash inflow from operating activities was 633 million yuan, down 0.60% year-on-year. The company's latest gross margin was 60.86%, a decrease of 3.40 percentage points from the same period last year; the latest ROE was 3.05%, a decrease of 1.33 percentage points from the same period last year. The company's diluted earnings per share was 0.27 yuan, down 27.69% year-on-year.
Lepu Medical Tech BeijingNet profit fell 27.71% year-on-year, with revenue down 4.61% and margins declining.
